Brief: Singular Genomics Systems Q2 EPS USD -0.35
09/08/2023 21:01
Aug 09 (Reuters) - Singular Genomics Systems Q2 operating income USD -27.603 million. * Q2 operating expenses USD 27.511 million * Q2 net income USD -25.578 million * Q2 revenue USD 505 thousand
Recent news on Singular Genomics Systems
See all newsBrief: Singular Genomics Systems Inc Deerfield Increases Purchase Price To $24.00 Per Share
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Concentra Biosciences And Tang Capital
Singular Genomics up after Tang Capital offers to buy it
Brief: Tang Capital Management, Llc Reports 14.9% Stake In Singular Genomics Systems Inc As Of Sept 16 - SEC Filing
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Deerfield